 | • レポートコード：D0GIR-02445 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール • 産業分類：サービス、ソフトウェア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、希少疾患遺伝子検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。希少疾患遺伝子検査の種類別市場規模（次世代シーケンシング（NGS）、アレイ技術、PCRベーステスト、蛍光in Situハイブリダイゼーション（FISH）、サンガーシーケンシング、核型分析、その他）、用途別市場規模（研究所・CRO、診断研究所、病院・診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Quest Diagnostics、Ambry Genetics、3billion、Centogene、Strand Life Sciences、Invitae Corporation、Macrogen、Eurofins Scientific、Arup Laboratories、Perkin Elmer、Coopersurgical、LabCorp、Baylor Genetics、Fulgent Genetics、Progenity、Color Genomics、Opko Health、Myriad Genetics、Preventiongenetics ・地域別グローバル市場分析 2015年-2020年 ・希少疾患遺伝子検査の北米市場（アメリカ、カナダ、メキシコ） ・希少疾患遺伝子検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・希少疾患遺伝子検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・希少疾患遺伝子検査の南米市場（ブラジル、アルゼンチン） ・希少疾患遺伝子検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：次世代シーケンシング（NGS）、アレイ技術、PCRベーステスト、蛍光in Situハイブリダイゼーション（FISH）、サンガーシーケンシング、核型分析、その他 ・用途別分析：研究所・CRO、診断研究所、病院・診療所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Rare Disease Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Rare Disease Genetic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Rare Disease Genetic Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rare Disease Genetic Testing market has been segmented into:
Next-Generation Sequencing (NGS)
Array Technology
PCR-based Testing
Fluorescence in Situ Hybridization (FISH)
Sanger Sequencing
Karyotyping
Others
By Application, Rare Disease Genetic Testing has been segmented into:
Research Laboratories and CROs
Diagnostic Laboratories
Hospitals and Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rare Disease Genetic Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Rare Disease Genetic Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rare Disease Genetic Testing market.
The report offers in-depth assessment of the growth and other aspects of the Rare Disease Genetic Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Rare Disease Genetic Testing Market Share Analysis
Rare Disease Genetic Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rare Disease Genetic Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rare Disease Genetic Testing sales, revenue and market share for each player covered in this report.
The major players covered in Rare Disease Genetic Testing are:
Quest Diagnostics
Ambry Genetics
3billion
Centogene
Strand Life Sciences
Invitae Corporation
Macrogen
Eurofins Scientific
Arup Laboratories
Perkin Elmer
Coopersurgical
LabCorp
Baylor Genetics
Fulgent Genetics
Progenity
Color Genomics
Opko Health
Myriad Genetics
Preventiongenetics
Among other players domestic and global, Rare Disease Genetic Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Rare Disease Genetic Testing Market Overview
1.1 Product Overview and Scope of Rare Disease Genetic Testing
1.2 Classification of Rare Disease Genetic Testing by Type
1.2.1 Global Rare Disease Genetic Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Rare Disease Genetic Testing Revenue Market Share by Type in 2019
1.2.3 Next-Generation Sequencing (NGS)
1.2.4 Array Technology
1.2.5 PCR-based Testing
1.2.6 Fluorescence in Situ Hybridization (FISH)
1.2.7 Sanger Sequencing
1.2.8 Karyotyping
1.2.9 Others
1.3 Global Rare Disease Genetic Testing Market by Application
1.3.1 Overview: Global Rare Disease Genetic Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research Laboratories and CROs
1.3.3 Diagnostic Laboratories
1.3.4 Hospitals and Clinics
1.3.5 Others
1.4 Global Rare Disease Genetic Testing Market by Regions
1.4.1 Global Rare Disease Genetic Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Rare Disease Genetic Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Rare Disease Genetic Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Rare Disease Genetic Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rare Disease Genetic Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Rare Disease Genetic Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rare Disease Genetic Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Quest Diagnostics
2.1.1 Quest Diagnostics Details
2.1.2 Quest Diagnostics Major Business
2.1.3 Quest Diagnostics SWOT Analysis
2.1.4 Quest Diagnostics Product and Services
2.1.5 Quest Diagnostics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ambry Genetics
2.2.1 Ambry Genetics Details
2.2.2 Ambry Genetics Major Business
2.2.3 Ambry Genetics SWOT Analysis
2.2.4 Ambry Genetics Product and Services
2.2.5 Ambry Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 3billion
2.3.1 3billion Details
2.3.2 3billion Major Business
2.3.3 3billion SWOT Analysis
2.3.4 3billion Product and Services
2.3.5 3billion Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Centogene
2.4.1 Centogene Details
2.4.2 Centogene Major Business
2.4.3 Centogene SWOT Analysis
2.4.4 Centogene Product and Services
2.4.5 Centogene Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Strand Life Sciences
2.5.1 Strand Life Sciences Details
2.5.2 Strand Life Sciences Major Business
2.5.3 Strand Life Sciences SWOT Analysis
2.5.4 Strand Life Sciences Product and Services
2.5.5 Strand Life Sciences Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Invitae Corporation
2.6.1 Invitae Corporation Details
2.6.2 Invitae Corporation Major Business
2.6.3 Invitae Corporation Product and Services
2.6.4 Invitae Corporation Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Macrogen
2.7.1 Macrogen Details
2.7.2 Macrogen Major Business
2.7.3 Macrogen Product and Services
2.7.4 Macrogen Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eurofins Scientific
2.8.1 Eurofins Scientific Details
2.8.2 Eurofins Scientific Major Business
2.8.3 Eurofins Scientific Product and Services
2.8.4 Eurofins Scientific Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Arup Laboratories
2.9.1 Arup Laboratories Details
2.9.2 Arup Laboratories Major Business
2.9.3 Arup Laboratories Product and Services
2.9.4 Arup Laboratories Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Perkin Elmer
2.10.1 Perkin Elmer Details
2.10.2 Perkin Elmer Major Business
2.10.3 Perkin Elmer Product and Services
2.10.4 Perkin Elmer Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Coopersurgical
2.11.1 Coopersurgical Details
2.11.2 Coopersurgical Major Business
2.11.3 Coopersurgical Product and Services
2.11.4 Coopersurgical Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.12 LabCorp
2.12.1 LabCorp Details
2.12.2 LabCorp Major Business
2.12.3 LabCorp Product and Services
2.12.4 LabCorp Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.13 Baylor Genetics
2.13.1 Baylor Genetics Details
2.13.2 Baylor Genetics Major Business
2.13.3 Baylor Genetics Product and Services
2.13.4 Baylor Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.14 Fulgent Genetics
2.14.1 Fulgent Genetics Details
2.14.2 Fulgent Genetics Major Business
2.14.3 Fulgent Genetics Product and Services
2.14.4 Fulgent Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.15 Progenity
2.15.1 Progenity Details
2.15.2 Progenity Major Business
2.15.3 Progenity Product and Services
2.15.4 Progenity Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.16 Color Genomics
2.16.1 Color Genomics Details
2.16.2 Color Genomics Major Business
2.16.3 Color Genomics Product and Services
2.16.4 Color Genomics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.17 Opko Health
2.17.1 Opko Health Details
2.17.2 Opko Health Major Business
2.17.3 Opko Health Product and Services
2.17.4 Opko Health Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.18 Myriad Genetics
2.18.1 Myriad Genetics Details
2.18.2 Myriad Genetics Major Business
2.18.3 Myriad Genetics Product and Services
2.18.3 Myriad Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.19 Preventiongenetics
2.19.1 Preventiongenetics Details
2.19.2 Preventiongenetics Major Business
2.19.3 Preventiongenetics Product and Services
2.19.4 Preventiongenetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Rare Disease Genetic Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Rare Disease Genetic Testing Players Market Share
3.2.2 Top 10 Rare Disease Genetic Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Rare Disease Genetic Testing Revenue and Market Share by Regions
4.2 North America Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
4.5 South America Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
5 North America Rare Disease Genetic Testing Revenue by Countries
5.1 North America Rare Disease Genetic Testing Revenue by Countries (2015-2020)
5.2 USA Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
6 Europe Rare Disease Genetic Testing Revenue by Countries
6.1 Europe Rare Disease Genetic Testing Revenue by Countries (2015-2020)
6.2 Germany Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
6.3 UK Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
6.4 France Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Rare Disease Genetic Testing Revenue by Countries
7.1 Asia-Pacific Rare Disease Genetic Testing Revenue by Countries (2015-2020)
7.2 China Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
7.5 India Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
8 South America Rare Disease Genetic Testing Revenue by Countries
8.1 South America Rare Disease Genetic Testing Revenue by Countries (2015-2020)
8.2 Brazil Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Rare Disease Genetic Testing by Countries
9.1 Middle East & Africa Rare Disease Genetic Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Rare Disease Genetic Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Rare Disease Genetic Testing Market Forecast by Type (2019-2024)
10.3 Next-Generation Sequencing (NGS) Revenue Growth Rate (2015-2025)
10.4 Array Technology Revenue Growth Rate (2015-2025)
10.5 PCR-based Testing Revenue Growth Rate (2015-2025)
10.6 Fluorescence in Situ Hybridization (FISH) Revenue Growth Rate (2015-2025)
10.7 Sanger Sequencing Revenue Growth Rate (2015-2025)
10.8 Karyotyping Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Rare Disease Genetic Testing Market Segment by Application
11.1 Global Rare Disease Genetic Testing Revenue Market Share by Application (2015-2020)
11.2 Rare Disease Genetic Testing Market Forecast by Application (2019-2024)
11.3 Research Laboratories and CROs Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Hospitals and Clinics Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Rare Disease Genetic Testing Market Size Forecast (2021-2025)
12.1 Global Rare Disease Genetic Testing Market Size Forecast (2021-2025)
12.2 Global Rare Disease Genetic Testing Market Forecast by Regions (2021-2025)
12.3 North America Rare Disease Genetic Testing Revenue Market Forecast (2021-2025)
12.4 Europe Rare Disease Genetic Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Rare Disease Genetic Testing Revenue Market Forecast (2021-2025)
12.6 South America Rare Disease Genetic Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Rare Disease Genetic Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Rare Disease Genetic Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rare Disease Genetic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rare Disease Genetic Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Rare Disease Genetic Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Rare Disease Genetic Testing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Quest Diagnostics Corporate Information, Location and Competitors
Table 7. Quest Diagnostics Rare Disease Genetic Testing Major Business
Table 8. Quest Diagnostics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 9. Quest Diagnostics SWOT Analysis
Table 10. Quest Diagnostics Rare Disease Genetic Testing Product and Solutions
Table 11. Quest Diagnostics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Ambry Genetics Corporate Information, Location and Competitors
Table 13. Ambry Genetics Rare Disease Genetic Testing Major Business
Table 14. Ambry Genetics Rare Disease Genetic Testing Total Revenue (USD Million) (2018-2019)
Table 15. Ambry Genetics SWOT Analysis
Table 16. Ambry Genetics Rare Disease Genetic Testing Product and Solutions
Table 17. Ambry Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. 3billion Corporate Information, Location and Competitors
Table 19. 3billion Rare Disease Genetic Testing Major Business
Table 20. 3billion Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 21. 3billion SWOT Analysis
Table 22. 3billion Rare Disease Genetic Testing Product and Solutions
Table 23. 3billion Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Centogene Corporate Information, Location and Competitors
Table 25. Centogene Rare Disease Genetic Testing Major Business
Table 26. Centogene Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 27. Centogene SWOT Analysis
Table 28. Centogene Rare Disease Genetic Testing Product and Solutions
Table 29. Centogene Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Strand Life Sciences Corporate Information, Location and Competitors
Table 31. Strand Life Sciences Rare Disease Genetic Testing Major Business
Table 32. Strand Life Sciences Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 33. Strand Life Sciences SWOT Analysis
Table 34. Strand Life Sciences Rare Disease Genetic Testing Product and Solutions
Table 35. Strand Life Sciences Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Invitae Corporation Corporate Information, Location and Competitors
Table 37. Invitae Corporation Rare Disease Genetic Testing Major Business
Table 38. Invitae Corporation Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 39. Invitae Corporation SWOT Analysis
Table 40. Invitae Corporation Rare Disease Genetic Testing Product and Solutions
Table 41. Invitae Corporation Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Macrogen Corporate Information, Location and Competitors
Table 43. Macrogen Rare Disease Genetic Testing Major Business
Table 44. Macrogen Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 45. Macrogen SWOT Analysis
Table 46. Macrogen Rare Disease Genetic Testing Product and Solutions
Table 47. Macrogen Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Eurofins Scientific Corporate Information, Location and Competitors
Table 49. Eurofins Scientific Rare Disease Genetic Testing Major Business
Table 50. Eurofins Scientific Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 51. Eurofins Scientific SWOT Analysis
Table 52. Eurofins Scientific Rare Disease Genetic Testing Product and Solutions
Table 53. Eurofins Scientific Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Arup Laboratories Corporate Information, Location and Competitors
Table 55. Arup Laboratories Rare Disease Genetic Testing Major Business
Table 56. Arup Laboratories Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 57. Arup Laboratories SWOT Analysis
Table 58. Arup Laboratories Rare Disease Genetic Testing Product and Solutions
Table 59. Arup Laboratories Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Perkin Elmer Corporate Information, Location and Competitors
Table 61. Perkin Elmer Rare Disease Genetic Testing Major Business
Table 62. Perkin Elmer Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 63. Perkin Elmer SWOT Analysis
Table 64. Perkin Elmer Rare Disease Genetic Testing Product and Solutions
Table 65. Perkin Elmer Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Coopersurgical Corporate Information, Location and Competitors
Table 67. Coopersurgical Rare Disease Genetic Testing Major Business
Table 68. Coopersurgical Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 69. Coopersurgical SWOT Analysis
Table 70. Coopersurgical Rare Disease Genetic Testing Product and Solutions
Table 71. Coopersurgical Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. LabCorp Corporate Information, Location and Competitors
Table 73. LabCorp Rare Disease Genetic Testing Major Business
Table 74. LabCorp Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 75. LabCorp SWOT Analysis
Table 76. LabCorp Rare Disease Genetic Testing Product and Solutions
Table 77. LabCorp Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Baylor Genetics Corporate Information, Location and Competitors
Table 79. Baylor Genetics Rare Disease Genetic Testing Major Business
Table 80. Baylor Genetics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 81. Baylor Genetics SWOT Analysis
Table 82. Baylor Genetics Rare Disease Genetic Testing Product and Solutions
Table 83. Baylor Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Fulgent Genetics Corporate Information, Location and Competitors
Table 85. Fulgent Genetics Rare Disease Genetic Testing Major Business
Table 86. Fulgent Genetics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 87. Fulgent Genetics SWOT Analysis
Table 88. Fulgent Genetics Rare Disease Genetic Testing Product and Solutions
Table 89. Fulgent Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Progenity Corporate Information, Location and Competitors
Table 91. Progenity Rare Disease Genetic Testing Major Business
Table 92. Progenity Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 93. Progenity SWOT Analysis
Table 94. Progenity Rare Disease Genetic Testing Product and Solutions
Table 95. Progenity Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Color Genomics Corporate Information, Location and Competitors
Table 97. Color Genomics Rare Disease Genetic Testing Major Business
Table 98. Color Genomics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 99. Color Genomics SWOT Analysis
Table 100. Color Genomics Rare Disease Genetic Testing Product and Solutions
Table 101. Color Genomics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Opko Health Corporate Information, Location and Competitors
Table 103. Opko Health Rare Disease Genetic Testing Major Business
Table 104. Opko Health Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 105. Opko Health SWOT Analysis
Table 106. Opko Health Rare Disease Genetic Testing Product and Solutions
Table 107. Opko Health Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Myriad Genetics Rare Disease Genetic Testing Type and Application
Table 109. Myriad Genetics Rare Disease Genetic Testing Major Business
Table 110. Myriad Genetics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 111. Myriad Genetics SWOT Analysis
Table 112. Myriad Genetics Rare Disease Genetic Testing Product and Solutions
Table 113. Myriad Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Preventiongenetics Corporate Information, Location and Competitors
Table 115. Preventiongenetics Rare Disease Genetic Testing Major Business
Table 116. Preventiongenetics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 117. Preventiongenetics SWOT Analysis
Table 118. Preventiongenetics Rare Disease Genetic Testing Product and Solutions
Table 119. Preventiongenetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Global Rare Disease Genetic Testing Revenue (Million USD) by Players (2015-2020)
Table 121. Global Rare Disease Genetic Testing Revenue Share by Players (2015-2020)
Table 122. Global Rare Disease Genetic Testing Revenue (Million USD) by Regions (2015-2020)
Table 123. Global Rare Disease Genetic Testing Revenue Market Share by Regions (2015-2020)
Table 124. North America Rare Disease Genetic Testing Revenue by Countries (2015-2020)
Table 125. North America Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 126. Europe Rare Disease Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 127. Asia-Pacific Rare Disease Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 128. South America Rare Disease Genetic Testing Revenue by Countries (2015-2020)
Table 129. South America Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 130. Middle East and Africa Rare Disease Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 131. Middle East and Africa Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 132. Global Rare Disease Genetic Testing Revenue (Million USD) by Type (2015-2020)
Table 133. Global Rare Disease Genetic Testing Revenue Share by Type (2015-2020)
Table 134. Global Rare Disease Genetic Testing Revenue Forecast by Type (2021-2025)
Table 135. Global Rare Disease Genetic Testing Revenue by Application (2015-2020)
Table 136. Global Rare Disease Genetic Testing Revenue Share by Application (2015-2020)
Table 137. Global Rare Disease Genetic Testing Revenue Forecast by Application (2021-2025)
Table 138. Global Rare Disease Genetic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Rare Disease Genetic Testing Picture
Figure 2. Global Rare Disease Genetic Testing Revenue Market Share by Type in 2019
Figure 3. Next-Generation Sequencing (NGS) Picture
Figure 4. Array Technology Picture
Figure 5. PCR-based Testing Picture
Figure 6. Fluorescence in Situ Hybridization (FISH) Picture
Figure 7. Sanger Sequencing Picture
Figure 8. Karyotyping Picture
Figure 9. Others Picture
Figure 10. Rare Disease Genetic Testing Revenue Market Share by Application in 2019
Figure 11. Research Laboratories and CROs Picture
Figure 12. Diagnostic Laboratories Picture
Figure 13. Hospitals and Clinics Picture
Figure 14. Others Picture
Figure 15. Global Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Rare Disease Genetic Testing Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Rare Disease Genetic Testing Revenue Market Share in 2019
Figure 24. Global Top 10 Players Rare Disease Genetic Testing Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Rare Disease Genetic Testing Revenue Market Share by Regions (2015-2020)
Figure 28. Global Rare Disease Genetic Testing Revenue Market Share by Regions in 2018
Figure 29. North America Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 30. Europe Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 32. South America Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 34. North America Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 35. North America Rare Disease Genetic Testing Revenue Market Share by Countries in 2019
Figure 36. USA Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 37. Canada Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 39. Europe Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Rare Disease Genetic Testing Revenue Market Share by Countries in 2019
Figure 41. Germany Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 42. UK Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 43. France Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 44. Russia Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 45. Italy Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Rare Disease Genetic Testing Revenue Market Share by Countries in 2019
Figure 48. China Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 49. Japan Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 50. Korea Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 51. India Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 53. South America Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 54. South America Rare Disease Genetic Testing Revenue Market Share by Countries in 2019
Figure 55. Brazil Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Rare Disease Genetic Testing Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 60. UAE Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Rare Disease Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 63. Global Rare Disease Genetic Testing Revenue Share by Type (2015-2020)
Figure 64. Global Rare Disease Genetic Testing Revenue Share by Type in 2019
Figure 65. Global Rare Disease Genetic Testing Market Share Forecast by Type (2021-2025)
Figure 66. Global Next-Generation Sequencing (NGS) Revenue Growth Rate (2015-2020)
Figure 67. Global Array Technology Revenue Growth Rate (2015-2020)
Figure 68. Global PCR-based Testing Revenue Growth Rate (2015-2020)
Figure 69. Global Fluorescence in Situ Hybridization (FISH) Revenue Growth Rate (2015-2020)
Figure 70. Global Sanger Sequencing Revenue Growth Rate (2015-2020)
Figure 71. Global Karyotyping Revenue Growth Rate (2015-2020)
Figure 72. Global Others Revenue Growth Rate (2015-2020)
Figure 73. Global Rare Disease Genetic Testing Revenue Share by Application (2015-2020)
Figure 74. Global Rare Disease Genetic Testing Revenue Share by Application in 2019
Figure 75. Global Rare Disease Genetic Testing Market Share Forecast by Application (2021-2025)
Figure 76. Global Research Laboratories and CROs Revenue Growth Rate (2015-2020)
Figure 77. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 78. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 79. Global Others Revenue Growth Rate (2015-2020)
Figure 80. Global Rare Disease Genetic Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Rare Disease Genetic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Rare Disease Genetic Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Rare Disease Genetic Testing Revenue Market Forecast (2021-2025)
Figure 84. Europe Rare Disease Genetic Testing Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Rare Disease Genetic Testing Revenue Market Forecast (2021-2025)
Figure 86. South America Rare Disease Genetic Testing Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Rare Disease Genetic Testing Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
遺伝病診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Genetic Disease Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genetic Disease Di…- 新生児および出生前遺伝子検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Newborn and Prenatal Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
- 消費者向け遺伝子検査（DTC）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Genetic Testing for Consumers (DTC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 希少内分泌疾患治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Rare Endocrine Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rare Endocri…
- 感染症検査における分子診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics in Infectious Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…